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The Correlation between Cancer
Incidence and Kava Consumption
Gregory G. Steiner DDS, MS
Background. A number of countries in the South Pacific have very
low cancer incidence. In spite of a high percentage of the population
habituated to tobacco, the cancer incidence in countries such as
_____________________________________________________
Vanuatu and Fiji experience age-standardized cancer incidence in
the 70’s. A number of studies have noted the low cancer incidence
in these countries and have postulated that a dietary chemopreventive
agent might be responsible.
Methods. The cancer incidence studies for the Pacific Islands were
completed in the 1980’s. During this time period accurate records
allow for a calculation of local kava consumption. This study
compares the cancer incidence for a number of Pacific Island
Nations with local kava consumption.
Results/Conclusions. The data indicates that the more kava con
sumed by a population the lower the cancer incidence for that
population. The data suggests there is a close inverse relationship
between cancer incidence and kava consumption.
Introduction
Cancer prevention is now a well-established medical science.
Chemoprevention has been described as the intervention with spe
cific agents to prevent, inhibit or reverse carcinogenesis before
malignancy. At this time there is a concerted effort to find effective
chemopreventive agents for cancer and also to subject these agents
to mechanistic studies to determine their mode of action.
The South Pacific Commission Cancer Registry was established
in 1977. Many South Pacific Nations have significantly lower
cancer incidence than other parts of the world. Table 1 lists the age-
standardized cancer incidence rates for males and females in the
Pacific Island Nations with Los Angeles Caucasians as a reference.
In 1985 Henderson et al published a paper on the cancer incidence
in the islands of the Pacific. He noted the high rate of smoking among
Fijians and postulated the low cancer incidence might be related to
chemopreventive actions of certain vitamins and trace elements
found in the diet.4 Paksoy et al studied the cancer incidence in
Western Samoa and also summarized other cancer incidence studies
for countries throughout the Pacific3.In conclusion Paksoy et al also
proposed that dietary protective factors might be responsible for the
low cancer rates found in some South Pacific Nations.
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In 1995 Le Marchand et al published a study on diet and lung
cancer in the South Pacific.7This study was population-based case-
controlled using data from Caucasian. Japanese Hawaiian, Filipino
and Chinese groups to investigate the role of diet in explaining lung
cancer incidence. He concluded much of the difference in lung
cancer incidence was explained by smoking and the chemopreventive
properties of lutein. He found that a very high number of Fijians
smoked but they smoked fewer cigarettes. The number of cigarettes
sold in Tahiti was used to confirm the data. In rural areas of the South
Pacific tobacco is a cultivated crop and tobacco is commonly sold
loose in local markets. It is possible the number of cigarettes
consumed in Fiji is higher when local production and consumption
of tobacco is calculated. However, when Le Marchand et al con
ducted the survey the amount of cigarettes consumed by Fijians was
recorded and is assumed to be accurate. Le Marchland et al was
unable to completely explain the low lung cancer incidence and
proposed that the difference might be related to the chemopreventive
actions of certain vitamins and trace elements in the diet.
Another possible explanation for the low cancer rates in Vanuatu,
Fiji, Western Samoa, and Micronesia could be the consumption of
kava.
Kava (Piper methysticum) is a plant indigenous to the Pacific
Islands. All major Pacific Islands developed kava as a beverage and
it is commonly consumed much like alcohol in western culture.
However, western intervention has resulted in a significant reduc
tion and sometimes the complete cessation of kava drinking in some
Table 1.— Age-standardized cancer incidence rates for all sites
males and females per 100,000 population
Country Incidence male Incidence female
Vanuatu 70.9 83.7
1198-77990.
Fiji2 75.0 112.2
(19791982)
Western Samoa3 90.2 93.7
(1980.1988)
Micronesia4 132.9 97.0
(1980-1982)
New Caledonia5 182.0 154.0
(977-1981)
Hawaii/Hawaiians6 3119* 297.6*
(1978-1982)
New Zealand/Maoris6 322.9* 297.6*
10.8-1*80.
USA. Los Angeles6 307.2* 276.2*
(1978-19821
* all sites but 173 (other skin)
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South Pacific Islands. Kava is traditionally prepared from the root of
the plant, which is worked in water to extract the active ingredients.
The active ingredients have been identified to be a group of com
pounds known as kavapyrones or kavalactones,
The commonly accepted actions of kava, which are referenced in
the literature, are as an anti-anxiety agent8,antidepressant9eupho
riant’°. muscle relaxant”, analgesic’2.and anti-convulsant’3.Kava
has become popular in the west as an anti-anxiety agent. No side
effects have been identified when used on a daily basis in moderate
amounts.’4
Materials and Methods
The cancer incidence studies for the Pacific Islands were com
pleted in the 1980’s (TABLE 1). During this time period we also
have the most accurate records of local kava consumption. Vanuatu
recognized the potential of kava as an export crop and conducted a
study in 1984 to count the plants growing in that country.’5With the
exception of Vanuatu, prior to the 1990’s, all production of kava can
be considered to be for local consumption. The kava production for
Fiji, Western Samoa and Micronesia is primarily for local consump
tion at least until the early 1990’s.’6 In the 1990’s kava became a
significant export crop for Vanuatu and Fiji.’6During the mid 1990’s
there was a significant increase in plantings of kava and also
sporadic harvesting of kava due to price fluctuations. For these
reasons the data presented is from the 1980’s in an effort to produce
the most accurate figures on the amount of kava consumed in the
various Pacific Island Nations..
In the 1980’s Vanuatu was the primary exporter of kava. It is
estimated that 20% of the production was exported outside the
Pacific. The remaining 80% ofVanuatu’s kavaproduction is consid
ered to be consumed locally. Irrespective of the figures used to
calculate the kava consumption in Vanuatu, it is obvious that this
country’s kava consumption per person far exceeds any other
country.
Reliable estimates are available for the number of plants being
cultivated in Vanuatu, Fiji, Western Samoa, Tonga and Micronesia.’6
In 1984 Vanuatu counted the number of plants being cultivated,
which totaled 2,605,635 plants.’ The number of hectares of kava
plants being cultivated totaled 4,200 hectares in Fiji, 800 hectares in
Western Samoa, 800 hectares in Tonga and 300 hectares in
Micronesia.’6New Caledonia does not cultivate kava but imports
approximately 100 tons of kava each year. Each hectare of cultiva
tion is estimated to hold 1000 plants.’5On average kava plants are
harvested after four years and replaced.’ The average plant when
harvested yields ten kilograms of fresh rootstock.’5When fresh
rootstock is dried it retains 20% of it original weight.’5
Kava plants on average are harvested after four years. Therefore,
each year 25% of the plants are processed. Each plant produces an
average of 10 kilograms of fresh rootstock, which, when dried yields
2 kilograms dried rootstock. The following formula provides us with
the amount of kilograms of dried kava root consumed each year.
There is no information on what percentage of males and females
drink kava in the countries being studied. Men will often stop at the
kava bar after work and enjoy bowls of kava with friends. While
women often drink kava the majority of kava consumption is by
men. We have no information on what percentage of people drink
kava or what percentage of men or women drink kava.. Because
kava consumption is believed to vary significantly for women in
each culture the cancer rate for males was used for comparison. As
discussed earlier the most accurate numbers for cancer rates and
kava consumption is from data gathered in the 1980’s. Therefore the
population figures that were used to calculate the kava consumption
per person is based on figures form l989.’
ResultslDiscussion
Table 2 lists the cancer incidence and kilograms of kava consumed
in each country. In every country the greater the amount of kava
consumption the lower the cancer incidence. The data from table 2
is displayed in chart 1. The Kingdom of Tonga is not charted due to
the author’s inability to determine the cancer incidence for this
country. There is a close inverse relationship between cancer inci
dence and kava consumption.
Table 2
Country Population Kilograms Cancer rate! Kilograms!
1989 consumed 100,000 males person
Vanuatu 155,000 1,042,252 70.9 6.7
Tonga 100,000 400,000 unknown 4.0
Fiji 749,000 2,100,000 75.0 2.8
Western Samoa 180,000 400,000 90.2 2.2
Micronesia 108,000 150,000 132.9 1.4
New Caledonia 161,000 100,000 182.0 0.6
Hawaiians 208,476 0 311.9 0.0
Chart 1.—Comparison of Cancer Incidence and Kava Consumption
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The results indicate a close correlation between kava consump
tion and a reduction in cancer incidence. However, if kava does
reduce the incidence of cancer it is improbable that kava consump
tion is solely responsible for the low cancer rate. It is possible that
the rate of cancer reporting has some effect due to the difficulty of
documenting all cancer cases in these remote islands. It is the
author’s belief that kava consumption reduces the amount of to
bacco consumed by smokers. If drinking kava reduces the amount
of tobacco consumed less cancer would be reflected in the kava
consumption data.
Age-standardized cancer incidence for kava drinking countries is
one-fourth to one-third the cancer incidence found in non kava
drinking countries and non kava drinking Polynesians. If kava was
solely responsible for the reduced cancer incidence it would be
expected that from 66% to 75% of the population drinks kava and
kava has the ability to completely prevent cancer. While there is no
data on the percentage of people that consumes kava it is considered
to be lower than 75% of the population. It is also unrealistic to
consider that kava could be 100 percent effective as a cancer
chemopreventive agent.
However, other factors support the conclusion that kava does play
a role in reducing cancer incidence. Men consume considerably
more kava than women. Out of approximately 150 cancer incidence
reporting locations in the world only approximately 10 report less
cancer for men than women. The three countries with the highest
kava consumption rates (Vanuatu, Fiji and Western Samoa) have a
lower incidence of cancer for males than females. In countries with
a lower rate of kava consumption (Micronesia and New Caledonia)
a more customary relationship of cancer incidence for males and
females is found.
Other than Vanuatu, there appears to be a direct correlation
between kava consumption and reduced cancer incidence. The
situation in Vanuatu might be explained by a number of factors. The
most obvious would be that if kava has a chemopreventive effect it
would be dose related. It would be understandable that after a certain
amount of kava consumption no further benefit is derived. Another
obvious factor is the number of people who do not drink kava. These
individuals would be expected to have normal cancer rates and
prevent the overall cancer incidence from dropping below a fixed
level.
Another indication that kava may play a part in reducing the
incidence of cancer is the normal rates of cancer found in the
indigenous people in New Zealand, French Polynesia and Hawaii.
In New Zealand the climate prohibits the cultivation of kava and in
French Polynesia and Hawaii western influence has eradicated the
kava culture. Normal cancer rates are found in the Pacific where
kava consumption is not common.
The data indicates a close inverse relationship between cancer
incidence and kava consumption. While the results of this study
suggests kava may be an effective cancer chemoprotective agent no
other conclusions can be made until further research is completed.
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There’s New Hope
About Stroke.
Today the outlook for stroke survivors is
better than ever. New drugs are reducing the
injury from stroke. And new rehabilitation
procedures are helping people regain lost
skills. But the key is still to get help fast. And
to do that, you must
Know the Warning Signs
• Sudden weakness or numbness of the
face, arm or leg on one side of the body.
• Sudden dimness or loss of vision, particu
larly in only one eye.
• Loss of speech, or trouble talking or
understanding speech.
• Sudden severe headaches with no
apparent cause.
• Unexplained dizziness, unsteadiness or
sudden falls, especially along with any of
the previous symptoms.
If you have any of the warning signs, don’t
wait! See a doctor right away!
American Heart
Association
Fighting Heart Disease
and Stroke
@1992, American Heart Associabon
Contact your local American Heart
Association or call 1 -800-AHA-USA1.
